Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$27,000.00

Engineering Enzymes Towards a True Universal Blood Type

EF 2024-25

Résumé
Blood transfusions are essential in healthcare. Whether used to replace blood lost in surgery or injury or as a blood supplement in patients with illnesses preventing proper development of blood, blood transfusions are life-saving. However, incompatibility in transfusions may result in severe reactions. As a result, ABO blood types between the host and donor must be matched carefully with blood typing. In emergency situations, especially when the host blood type is unknown, the blood type O negative is used. Absent of surface antigens of A or B that are the source of the immune responses experienced when blood type mismatch occurs, O negative type blood is in high demand as it will not trigger immune responses in hosts regardless of the recipient blood type. With only 7% of the Canadian population having this blood type, there is a constant need for this universal type of blood in hospitals. The creation of a true universal blood type has thus been a topic of great interest, with this discovery allowing for transfusions without fear of blood type incompatibility and improving the persistent global shortage of O negative type blood. Recent research has shown that the A and B carbohydrate-based antigens located on the surfaces of red blood cells (RBCs) are able to be enzymatically converted to the universal type O blood. However, apart from the major A and B antigens on RBC surfaces, there are various protein-based antigens and around 370 minor antigens that may result in immune responses. As a result, there are no current methods available to generate true universal blood where all antigens are either masked or cleaved. My project will address this gap by investigating methods to develop true universal blood by masking or cleaving all RBC surface antigens.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
530002
Name
Lin Michelle C
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Engineering Enzymes Towards a True Universal Blood Type
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Blood Research; Blood Transfusions; Blood Typing; Cell Surface Engineering; Enzyme Engineering
Abstract
Blood transfusions are essential in healthcare. Whether used to replace blood lost in surgery or injury or as a blood supplement in patients with illnesses preventing proper development of blood, blood transfusions are life-saving. However, incompatibility in transfusions may result in severe reactions. As a result, ABO blood types between the host and donor must be matched carefully with blood typing. In emergency situations, especially when the host blood type is unknown, the blood type O negative is used. Absent of surface antigens of A or B that are the source of the immune responses experienced when blood type mismatch occurs, O negative type blood is in high demand as it will not trigger immune responses in hosts regardless of the recipient blood type. With only 7% of the Canadian population having this blood type, there is a constant need for this universal type of blood in hospitals. The creation of a true universal blood type has thus been a topic of great interest, with this discovery allowing for transfusions without fear of blood type incompatibility and improving the persistent global shortage of O negative type blood. Recent research has shown that the A and B carbohydrate-based antigens located on the surfaces of red blood cells (RBCs) are able to be enzymatically converted to the universal type O blood. However, apart from the major A and B antigens on RBC surfaces, there are various protein-based antigens and around 370 minor antigens that may result in immune responses. As a result, there are no current methods available to generate true universal blood where all antigens are either masked or cleaved. My project will address this gap by investigating methods to develop true universal blood by masking or cleaving all RBC surface antigens.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lin, Michelle C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~